Predict your next investment

Hedge Fund

See what CB Insights has to offer

Investments

1

Portfolio Exits

1

About Hound Partners

Hound Partners is a New York-based hedge fund manager.

Hound Partners Headquarter Location

101 Park Avenue 48th Floor

New York, New York, 10178,

United States

212-984-2326

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Hound Partners

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Hound Partners in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Latest Hound Partners News

Metro Bank : U.S. hedge fund Hound Partners discloses 5 percent stake in UK's Metro Bank

Feb 8, 2019

0 Message : *Required fields (Reuters) - U.S. hedge fund Hound Partners disclosed a 5.05 percent stake in British lender Metro Bank Plc, a filing showed on Friday. The stake would make Hound Partners Metro Bank's sixth biggest investor, according to Refinitiv Eikon data. Metro Bank last month announced a sharp rise in exposure to higher-risk mortgages and said profits would be hit by slowing growth, raising fears of a shareholder cash call.

Hound Partners Investments

1 Investments

Hound Partners has made 1 investments. Their latest investment was in Lev Pharmaceuticals as part of their Unattributed VC on October 10, 2006.

CBI Logo

Hound Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/11/2006

Unattributed VC

Lev Pharmaceuticals

$21M

Yes

Date

10/11/2006

Round

Unattributed VC

Company

Lev Pharmaceuticals

Amount

$21M

New?

Yes

Co-Investors

Sources

Hound Partners Portfolio Exits

1 Portfolio Exit

Hound Partners has 1 portfolio exit. Their latest portfolio exit was Lev Pharmaceuticals on October 07, 2008.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/7/2008

Acquired

$991

Date

10/7/2008

Exit

Acquired

Companies

Valuation

$991

Acquirer

Sources

Hound Partners Team

1 Team Member

Hound Partners has 1 team member, including undefined undefined, undefined.

Name

Work History

Title

Status

Jonathan Auerbach

Stark Investments, and W.R. Huff Investment Arm

Founder

Current

Name

Jonathan Auerbach

Work History

Stark Investments, and W.R. Huff Investment Arm

Title

Founder

Status

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.